Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PPCB will decline by -28.63% over the next 2 Weeks and hit $1.59 by Thursday, September 10, 2026. In that time frame, PPCB's share price is expected to range between $1.37 and $1.81.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 10, 2026 | 1.37 | 1.59 | 1.81 |
| Sep 9, 2026 | 1.18 | 1.40 | 1.62 |
| Sep 8, 2026 | 1.26 | 1.50 | 1.71 |
| Sep 7, 2026 | 1.28 | 1.51 | 1.72 |
| Sep 4, 2026 | 1.32 | 1.54 | 1.75 |
| Sep 3, 2026 | 1.45 | 1.67 | 1.90 |
| Sep 2, 2026 | 1.25 | 1.48 | 1.72 |
| Sep 1, 2026 | 1.35 | 1.57 | 1.79 |
| Aug 31, 2026 | 1.36 | 1.59 | 1.82 |
| Aug 28, 2026 | 1.39 | 1.61 | 1.84 |
PPCB shares rose +108.41% in Thursday, August 27, 2026's trading session, rising from a previous close of $1.07 to move at $2.23. The stock demonstrated notable intraday movement (see PPCB's key stats for a full breakdown), fluctuating between $1.99 and $4.13, a +107.54% trading range. While recent weeks have seen some volatility, PPCB has managed to secure a +82.79% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 96.64M shares changing hands, 96.63M more than the previous session. This amounted to $215.50M in total market activity.
Will PPCB Continue Its Downward Trend?
According to analyst ratings and projections for PPCB, Propanc Biopharma, Inc. shares are anticipated to decrease by -22.93%, potentially reaching $1.81 per share by September 10, 2026. Short-term technical indicators for PPCB currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the PPCB stock forecast, now is not the best time to buy PPCB stock because its current trading price is +40.11% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PPCB covering social and institutional perspectives.
PPCB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PPCB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 68.52% to 83.98%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 45.96%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.14%, maintains a neutral outlook for the long term. Insights into PPCB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Propanc Biopharma Short-Term Forecasts
PPCB Forecast For Next 5 Days
Our algorithm anticipates Propanc Biopharma (PPCB) stock could hit $0.89 by Sep 03, 2026. This represents a -60.18% fall from today's price, following a -34.05% change over the past five days.
PPCB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Propanc Biopharma, Inc. (PPCB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.92, which would mean a -58.74% decrease from the current price of $2.23. Projections for this period range from a high of $1.35 to a low of $0.57.
PPCB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Propanc Biopharma's price over the next three months point to a drop. PPCB stock is expected to peak at $3.82 on Aug 28, 2026 before potentially dipping to $1.17 on Nov 27, 2026. On average, PPCB is likely to trade around $2.18 in the coming 90 days.
Propanc Biopharma Stock Forecast 2025
Based on our predictive models, Propanc Biopharma (PPCB) is expected to trade between $0.90 and $3.82 throughout 2026. This would result in an average price of $1.91, potentially offering investors a -14.35% return from current levels.
Propanc Biopharma, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Propanc Biopharma, Inc. (PPCB) is positioned to show a strong performance in August 2026. The price is predicted to move between $3.44 and $3.82, settling at an average of $3.62. This could translate to a +62.33% gain.
September 2026
Based on current market signals, Propanc Biopharma, Inc. is projected to trend september 2026. We forecast a trading range from $2.26 to $3.54, with a likely average price of $2.66. Investors could expect a potential return of +19.28%.
October 2026
Our predictive algorithms indicate Propanc Biopharma, Inc. stock may see a shift in October 2026. The expected range spans $1.66–$2.66, with an average target of $2.07. This represents a cautious outlook and a possible loss of -7.17%.
November 2026
Analyzing established trends, Propanc Biopharma, Inc. looks set to move in November 2026. Projections place the stock between $1.03 and $2.04, averaging around $1.62. This suggests a -27.35% loss from current levels.
December 2026
Market indicators suggest Propanc Biopharma, Inc. could experience notable changes during December 2026. Prices could fluctuate within $0.90 to $1.38, with a midpoint forecast of $1.16. The stock might deliver a -47.98% loss.
January 2027
Forecasting for January 2027, models estimate that Propanc Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.49 and $1.27, averaging $0.88. This signals a cautious trajectory with potential returns around -60.54%.
February 2027
According to our latest forecast models, Propanc Biopharma, Inc. (PPCB) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.37 and $0.75, settling at an average of $0.56. This could translate to a -74.89% loss.
March 2027
Based on current market signals, Propanc Biopharma, Inc. is projected to trend march 2027. We forecast a trading range from $0.21 to $0.64, with a likely average price of $0.42. Investors could expect a potential return of -81.17%.
April 2027
Our predictive algorithms indicate Propanc Biopharma, Inc. stock may see a shift in April 2027. The expected range spans $0.16–$0.53, with an average target of $0.34. This represents a cautious outlook and a possible loss of -84.75%.
May 2027
Analyzing established trends, Propanc Biopharma, Inc. looks set to move in May 2027. Projections place the stock between $0.05 and $0.45, averaging around $0.26. This suggests a -88.34% loss from current levels.
June 2027
Market indicators suggest Propanc Biopharma, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.04 to $0.36, with a midpoint forecast of $0.20. The stock might deliver a -91.03% loss.
July 2027
Forecasting for July 2027, models estimate that Propanc Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.33, averaging $0.16. This signals a cautious trajectory with potential returns around -92.83%.
August 2027
According to our latest forecast models, Propanc Biopharma, Inc. (PPCB) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $0.28, settling at an average of $0.13. This could translate to a -94.17% loss.
PPCB's history of dividends and stock splits also plays a role in long-term investor confidence.